Medications

India patent case threatens cheap drug supply: MSF

Supply of cheap, copycat drugs for the developing world could be badly threatened if Swiss firm Novartis wins a challenge to India's patent law, medical charity MSF said on Monday.

Oncology & Cancer

Myriad can patent breast cancer genes: US court

A federal appeals court on Friday ruled in favor of Myriad Genetics after a legal battle over whether the US company could keep its patent on genes linked to an inherited form of breast cancer.

Other

Pharma lobby blasts 'stupid' pandemic patent plans

Stripping patent protection from COVID-19 treatments is a "mind-bogglingly stupid" idea, the head of a leading pharmaceutical lobby said Wednesday, warning that the move would put industry innovation at risk.

Vaccination

Moderna sues Pfizer, BioNTech over COVID vaccine

Moderna said Friday it is suing rival vaccine makers Pfizer and BioNTech, alleging the partners infringed on its patents in developing their COVID-19 shot administered to hundreds of millions around the world.

Vaccination

What's at stake in COVID-19 jab patent waiver row

Over a year into global COVID-19 vaccination efforts the question of whether jab formulas ought to be freely available is still unresolved—and undersupplied countries are turning to workarounds.

page 18 from 26